Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Effect and safety of immunotherapy among elder patients (age ≥ 65) with recurrent or metastatic nasopharyngeal carcinoma

Fig. 1

Risk factors for Progression-Free Survival (PFS). A Multivariable Cox proportional hazards model of PFS in RM-NPC patients stratified by local therapy, adjusted by liver metastasis. B Restricted Mean Survival Curves for PFS between with and without local therapy. C Multivariable Cox proportional hazards model of PFS in RM-NPC patients stratified by liver metastasis, adjusted by local therapy

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us